In conclusion, high plasma GDF15 concentrations are significantly associated with combined cognitive-frailty-and-depression status, with both conditions separately as well as with global cognitive functioning and self-rated depression scores in old as well as young community-dwelling adults of the MARK-AGE study. This evidence concerns the gene GDF15 and major depressive disorder.